{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:19:49Z","timestamp":1743826789462,"version":"3.40.3"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec012\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Hematological malignancies and allogeneic hematopoietic cell transplantation (alloHCT) often necessitate the use of opioids due to significant pain. This study aimed to investigate the impact of opioid use on the clinical outcomes of patients undergoing alloHCT.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec013\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A retrospective cohort study was conducted by merging data from our local transplant database with anonymized pharmacy records obtained from the Institute for Clinical Evaluative Sciences (ICES). We analyzed 681 patients who underwent alloHCT at Princess Margaret Cancer Centre between January 2010 and December 2019. Patients who initiated opioid use within one-year post-alloHCT and had opioid prescriptions for more than 30 days were categorized as intense opioid users (IOU). Additionally, patients who started opioids before or within one-year post-alloHCT and had opioid prescriptions for less than 30 days but died while on opioids were also classified as IOU. The analytical code used for the analysis is available in the Supporting Information file.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec014\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among the 681 patients, 51 were identified as IOU. The two-year overall survival (OS) was significantly lower in the IOU group, with 29.4% survival compared to 53% in non-IOU (HR 1.77, 95% CI 1.26\u20132.48, p\u2009=\u20090.0008). Multivariate analysis indicated that IOU status was associated with a 2.32 times higher instantaneous rate of death compared to non-IOU (HR 2.32, 95% CI 1.5\u20133.5, p\u2009=\u20090.002). The median time for relapse was 147 days in the IOU group (range 52\u2013393) and 209 day for non-IOU (range 96\u20131793), p\u2009=\u20090.0082. Furthermore, the relapse rate at two years was notably higher in the IOU group (31.4% vs. 16.4%, p\u2009=\u20090.0049). The analysis of factors independently associated with relapse-free survival (LFS) showed that IOU status, age, donor type, and cytogenetic risk were significant predictors. At two years, relapse-free survival was 29.4% in the IOU group compared to 52.5% in the non-IOU group (p\u2009&lt;\u20090.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec015\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In our study, we found a correlation between intense opioid use in alloHCT patients and worse overall survival, particularly concerning higher relapse rates. These findings highlight the need for further research into pain management strategies to improve outcomes and reduce potential toxicity.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0321073","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:47:44Z","timestamp":1743788864000},"page":"e0321073","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4171-4678","authenticated-orcid":true,"given":"Tommy","family":"Alfaro Moya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel Santos","family":"Carreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Refik","family":"Saskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Novitzky-Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-6644","authenticated-orcid":true,"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"pone.0321073.ref001","volume-title":"Guidelines on the management of chronic pain in children","year":"2020"},{"issue":"26","key":"pone.0321073.ref002","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood.2019003116","article-title":"How I treat pain in hematologic malignancies safely with opioid therapy","volume":"135","author":"HL Geyer","year":"2020","journal-title":"Blood"},{"issue":"8","key":"pone.0321073.ref003","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00277-005-0062-4","article-title":"Opioids in pain management of blood-related malignancies","volume":"85","author":"P Niscola","year":"2006","journal-title":"Ann Hematol"},{"key":"pone.0321073.ref004","unstructured":"World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. 2018:138."},{"key":"pone.0321073.ref005","doi-asserted-by":"crossref","unstructured":"Hedegaard H, Warner M. Drug overdose deaths in the United States, 1999\u20132020. 2021.","DOI":"10.15620\/cdc:112340"},{"key":"pone.0321073.ref006","volume-title":"Opioid Prescribing in Canada: How Are Practices Changing?","author":"Canadian Institute for Health Information.","year":"2019"},{"issue":"12","key":"pone.0321073.ref007","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/cncr.31303","article-title":"Cancer pain management and the opioid crisis in America: How to preserve hard-earned gains in improving the quality of cancer pain management","volume":"124","author":"JA Paice","year":"2018","journal-title":"Cancer"},{"key":"pone.0321073.ref008","first-page":"100813","article-title":"Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019 to 2022","volume":"36","author":"AH H\u00e9bert","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"3","key":"pone.0321073.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain \u2014 United States, 2022","volume":"71","author":"D Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"pone.0321073.ref010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.3","article-title":"Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies","volume":"41","author":"P Niscola","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"pone.0321073.ref011","doi-asserted-by":"crossref","first-page":"S249-50","DOI":"10.1016\/j.bbmt.2014.11.392","article-title":"Pain following hematopoietic stem cell transplant: A prospective observational study","volume":"21","author":"J Galvin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"pone.0321073.ref012","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbmt.2005.02.006","article-title":"Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens","volume":"11","author":"C Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"pone.0321073.ref013","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3324\/haematol.10232","article-title":"Mucositis in patients with hematologic malignancies: An overview","volume":"92","author":"P Niscola","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"pone.0321073.ref014","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00002820-199912000-00001","article-title":"Pain in adult recipients of blood or marrow transplant","volume":"22","author":"C Pederson","year":"1999","journal-title":"Cancer Nurs"},{"issue":"3","key":"pone.0321073.ref015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5045\/br.2020.2020056","article-title":"Drug use evaluation of opioid analgesics in pain management among patients with hematopoietic stem cell transplantation","volume":"55","author":"H Oh","year":"2020","journal-title":"BLOOD Res"},{"issue":"12","key":"pone.0321073.ref016","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: Working definitions","volume":"15","author":"A Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"pone.0321073.ref017","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"D Grimwade","year":"2010","journal-title":"Blood"},{"issue":"12","key":"pone.0321073.ref018","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"H D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"10208","key":"pone.0321073.ref019","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: harms to populations, interventions, and future action","volume":"394","author":"L Degenhardt","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"pone.0321073.ref020","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/jpepsy\/jsu072","article-title":"Opioid misuse behaviors in adolescents and young adults in a hematology\/oncology setting","volume":"39","author":"JH Ehrentraut","year":"2014","journal-title":"J Pediatr Psychol"},{"key":"pone.0321073.ref021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2018.11.024","article-title":"Urban-rural variation in the socioeconomic determinants of opioid overdose","volume":"195","author":"VA Pear","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0321073.ref022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12954-023-00736-7","article-title":"Racial\/ethnic disparities in opioid overdose prevention: Comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City","volume":"20","author":"M Khan","year":"2023","journal-title":"Harm Reduct J"},{"issue":"6","key":"pone.0321073.ref023","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/bmt.2015.44","article-title":"Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites","volume":"50","author":"BK Hamilton","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"pone.0321073.ref024","first-page":"346.e1-346.e10","article-title":"Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research","volume":"29","author":"JJ Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"pone.0321073.ref025","article-title":"Employment status as an indicator of recovery and function one year after hematopoietic stem cell transplantation","author":"E Morrison","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"pone.0321073.ref026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ypmed.2016.08.003","article-title":"The influence of prescription opioid use duration and dose on development of treatment resistant depression","volume":"91","author":"JF Scherrer","year":"2016","journal-title":"Prev Med"},{"issue":"5","key":"pone.0321073.ref027","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpain.2015.01.475","article-title":"Defining risk of prescription opioid overdose: Pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid","volume":"16","author":"Z Yang","year":"2015","journal-title":"J Pain"},{"issue":"5","key":"pone.0321073.ref028","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bja.2019.08.012","article-title":"Trends in chronic opioid use and association with five-year survival in South Korea: A population-based cohort study","volume":"123","author":"TK Oh","year":"2019","journal-title":"Br J Anaesth"},{"issue":"3","key":"pone.0321073.ref029","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/lt.24714","article-title":"Survival implications of opioid use before and after liver transplantation","volume":"23","author":"HB Randall","year":"2017","journal-title":"Liver Transpl"},{"issue":"9","key":"pone.0321073.ref030","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/crj.12948","article-title":"Chronic opioid use and clinical outcomes in lung transplant recipients: A single-center cohort study","volume":"12","author":"D Drees","year":"2018","journal-title":"Clin Respir J"},{"issue":"12","key":"pone.0321073.ref031","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1111\/ajt.15565","article-title":"Prescription opioid use before and after heart transplant: Associations with posttransplant outcomes","volume":"19","author":"KL Lentine","year":"2019","journal-title":"Am J Transplant"},{"issue":"9","key":"pone.0321073.ref032","doi-asserted-by":"crossref","first-page":"e19306","DOI":"10.1097\/MD.0000000000019306","article-title":"The impact of pain and opioids use on survival in cancer patients: Results from a population-based cohort study and a meta-analysis","volume":"99","author":"J Zheng","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"pone.0321073.ref033","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00520-018-4062-z","article-title":"Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies","volume":"26","author":"D Zylla","year":"2018","journal-title":"Support Care Cancer"},{"issue":"10","key":"pone.0321073.ref034","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/j.pain.0000000000001630","article-title":"Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer","volume":"160","author":"DB Nelson","year":"2019","journal-title":"Pain"},{"issue":"1","key":"pone.0321073.ref035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12904-016-0169-5","article-title":"The association between different opioid doses and the survival of advanced cancer patients receiving palliative care","volume":"15","author":"A Sathornviriyapong","year":"2016","journal-title":"BMC Palliat Care"},{"issue":"6","key":"pone.0321073.ref036","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpainsymman.2006.08.003","article-title":"Opioid use and survival at the end of life: A survey of a hospice population","volume":"32","author":"RK Portenoy","year":"2006","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"pone.0321073.ref037","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.21037\/apm-22-691","article-title":"Supportive care and symptom management in patients with advanced hematological malignancies: A literature review","volume":"11","author":"KY Chan","year":"2022","journal-title":"Ann Palliat Med"},{"issue":"9","key":"pone.0321073.ref038","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/cncr.32736","article-title":"Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report","volume":"126","author":"N Farrukh","year":"2020","journal-title":"Cancer"},{"issue":"Supplement 1","key":"pone.0321073.ref039","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1182\/blood-2022-171045","article-title":"Chronic Opioid Use Is Highly Prevalent and Associated with Inferior Survival in Myeloma Patients in Remission after Autologous Transplant","volume":"140","author":"K Sweiss","year":"2022","journal-title":"Blood"},{"issue":"Supplement 1","key":"pone.0321073.ref040","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2021-154472","article-title":"Chronic Opioid Use Is Highly Prevalent in Patients Undergoing Allogeneic Transplant and Impacts Long Term Outcomes","volume":"138","author":"K Sweiss","year":"2021","journal-title":"Blood"},{"issue":"9","key":"pone.0321073.ref041","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/cncr.32736","article-title":"Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report.","volume":"126","author":"N Farrukh","year":"2020","journal-title":"Cancer"},{"issue":"14","key":"pone.0321073.ref042","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1111\/bph.13903","article-title":"Influence of opioids on immune function in patients with cancer pain: from bench to bedside","volume":"175","author":"JW Boland","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"14","key":"pone.0321073.ref043","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system \u2013 friend or foe","volume":"175","author":"LM Plein","year":"2018","journal-title":"Br J Pharmacol"},{"key":"pone.0321073.ref044","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","article-title":"The role of opioid receptors in immune system function","volume":"10","author":"T Eisenstein","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"pone.0321073.ref045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14740\/jh689","article-title":"Impact of opioid use in hematological malignancies: Clinical, immunological and concomitant aspects","volume":"9","author":"P Tregubenko","year":"2020","journal-title":"J Hematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:49:20Z","timestamp":1743788960000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321073"}},"subtitle":[],"editor":[{"given":"Monia","family":"Marchetti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321073","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}